Ratio Therapeutics
Ratio Therapeutics develops radiotherapeutics for the treatment of cancers. They engaged in research and development platforms, trillium and macropa, enable the imaging, discovery, and advancement of radiopharmaceuticals. It enables doctors to detect a wide range of epithelial-derived cancers, such as breast, pancreatic, lung, colon cancers, and more.
Tech Stack (15 technologies)
Frequently Asked Questions
What technologies does Ratio Therapeutics use?+
Ratio Therapeutics uses 15 technologies including All in One SEO Pack, Google Analytics, Google Tag Manager.
What industry is Ratio Therapeutics in?+
Ratio Therapeutics operates in the Biopharma industry.
Where is Ratio Therapeutics based?+
Ratio Therapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026